ZEISS Unveils Innovative Digital Solutions at AAO 2026 for Enhanced Ophthalmic Workflows

ZEISS Showcases Cutting-Edge Technologies at AAO 2026

At the upcoming American Academy of Ophthalmology (AAO) annual meeting in New Orleans, taking place from October 10-12, ZEISS Medical Technology is set to present a variety of cutting-edge digital and visual advancements aimed at improving ophthalmic workflows. Among these developments includes the highly anticipated ZEISS VERACITY Surgery Planner, which has successfully planned over 3 million surgical cases through its cloud-based software. This innovative technology supports surgical efficiency by automating routine tasks and ensuring accurate data management, allowing clinicians to create comprehensive surgical plans effortlessly.

The event also highlights ZEISS's commitment to ergonomic solutions in the operating theater with the introduction of the HMDmd CR3, a head-mounted 3D digital display. This device enhances surgical visualization, ensuring that surgeons maintain a comfortable head position while viewing critical information during procedures. Such innovative tools are pivotal in maintaining a high standard of care throughout various surgical workflows.

At the AAO, ZEISS will celebrate another impressive milestone as it acknowledges that over 1 million procedures utilizing DORC TissueBlue® (Brilliant Blue G Ophthalmic Solution) have been conducted in the U.S. This FDA-approved disclosing agent aids in the selective staining of the internal limiting membrane (ILM), enhancing surgical precision during delicate eye operations.

In addition, ZEISS is excited to introduce the updated ATLAS 500 corneal topographer, which boasts multi-modality solutions for assessing ocular surface diseases. The device connects with the ZEISS FORUM, facilitating efficient patient scheduling and data management, further optimizing the practice’s workflow.

Furthermore, ZEISS celebrates a significant global milestone of treating over 15 million eyes with its revolutionary SMILE® and SMILE pro® refractive procedures, demonstrating seamless technology adoption by refractive surgeons worldwide. This rapid growth since reaching 10 million treated eyes just two years ago reflects the trust physicians place in ZEISS's refractive surgery technology.

Improving the online presence of ophthalmic practices is another area where ZEISS is making strides. The launch of the ZEISS VisioGen Practice Visibility Accelerator is designed to enhance a practice’s website and overall online visibility, supporting improved patient engagement and outcomes. This innovation showcases ZEISS's commitment to empowering practices with the tools necessary for growth and visibility.

ZEISS is broadening its glaucoma diagnostics portfolio with the upcoming ZEISS MATRIX-VR headset perimeter. This innovative solution, currently in development, allows for a more flexible and engaging patient experience during visual field screenings. Coupled with existing technologies, this has the potential to optimize the workflow in glaucoma management significantly.

Moreover, ZEISS is excited to present CLINIC 360, a recently FDA-cleared digital management tool designed to streamline workflows in eye care practices. This cloud-based system provides practitioners with essential analytics and data management capabilities, allowing for a tailored approach to patient care and practice efficiency.

The array of groundbreaking technologies showcased at AAO 2026 highlights ZEISS's dedication to innovation and excellence in ophthalmology. Attendees are encouraged to visit the ZEISS booth 3719 for live demonstrations and insights from industry leaders, helping to shape the future of eye care.